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Abstract
Matthew DiCerbo
POROUS SCAFFOLD AND SOFT HYDROGEL COMPOSITE FOR BIOMEDICAL
APPLICATIONS
2020-2021
Sebastián L. Vega, Ph.D.
Master of Science in Biomedical Engineering

Biophysical signals including stiffness and dimensionality influence a myriad of
stem cell behaviors including morphology, mechanosensing, and differentiation. 2D stiff
environments cause increased cellular spreading and induce osteogenic differentiation
whereas 3D soft environments favor rounder cell morphologies attributed to a
chondrogenic phenotype. The goal of this study is to create a composite that integrates
these divergent biophysical signals within one system. This composite consists of a stiff
and porous polycaprolactone (PCL) backbone that provides mechanical stiffness and a 2D
environment. The PCL backbone is then perfused with mesenchymal stem cells (MSCs)
and a soft methacrylated gelatin (GelMe) hydrogel to provide an encapsulation technique
that exposes cells to a soft 3D environment. Interestingly, MSCs in these composites
exhibited differences in morphology and mechanosensing based on pore diameter. MSCs
cultured in low pore size (~275 µm) composites were larger and more mechanically active
than MSCs in high pore size (~425 µm) composites. Our finite element analysis models
suggest that the role of pore size on cellular mechanosensing is linked to local changes in
hydrogel stress from PCL-GelMe interactions. This composite is currently being explored
for engineering the osteochondral tissue interface which contains a mixed population of
osteoblasts and chondrocytes.
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Chapter 1
Motivation
Treatment techniques to replace or replenish articular cartilage and the
osteochondral interface (OI) are increasing at a rapid scale. However, successful repair of
the osteochondral interface and specifically, osteochondral defects require the replacement
or regeneration of multiple tissue phenotypes and recreation of a heterogeneous cellular
environment[1]. This factor presents a substantial clinical and scientific challenge in
replicating these properties.

Figure 1
Synovial Joint Comparison. Comparison of synovial joints as osteoarthritis progresses. A)
Synovial joint with no osteoarthritis. B) Synovial joint with mild arthritis. C) Synovial joint
with severe osteoarthrosis. [2]
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Articular cartilage lesions and defects are an increasing problem in orthopedics and
are being encountered consistently and commonly lead to long term consequences. A
collection of data shows out of 31,516 knee arthroscopies, chondral lesions were reported
in 63% of patients in the study [1], [3]. These lesions are significant and need proper
attention because they most likely will lead to degeneration of the joint and osteoarthritis
(OA) [4]. Comparison of synovial joints as osteoarthritis progresses is shown in Figure 1.
OA is very common among all types of patients especially those with joint injury, obesity,
and predisposition. It is estimated from the recent burden of disease that up to 250 million
of the world’s population has osteoarthritis and the number will continue to increase [5].
Osteoarthritis is defined by musculoskeletal scientists and clinicians to be “chronic
condition of the synovial joint that develops over time and is the result of the damaging
processes overwhelming the joint’s ability to repair itself [5].” OA is an active dynamic
process occurring from an imbalance between the repair and destruction of the joint’s
tissue[6], [7]. The knee joint is the most common site for osteoarthritis to progress as it is
subjected to constant loading throughout its lifetime [8].
It has recently been discovered that OA is not solely limited to the articular surface
and that its onset may be initiated through activation of the secondary center of ossification
which causes thinning of overlying cartilage resulting from thickening of the subchondral
bone unit [9], [10]. These findings support OA is a whole joint disease and involves
changes to the hyaline cartilage, subchondral bone, ligaments, synovium, and other
components of the joint [8]. As osteoarthritis progresses, cartilage composition changes
and the cartilage layer lose viscoelastic properties and integrity [11]. Susceptibility to
physical forces increases because of compositional changes to the cartilages material
2

properties and these susceptibilities have a negative downstream effect on patients. A
pathological image of an OA joint is shown in Figure 2. Erosions start at the surface of the
cartilage and then more deep cartilage fissures are accompanied with expansion of the
calcified cartilage zone. Chondrocytes try to repair this problem but essentially make it
more complicated by increasing synthetic activity. In return, matrix degradation products
and proinflammatory mediators are generated and deregulate chondrocyte function and act
on the adjacent synovium to generate inflammatory and proliferative responses. When
synoviocytes proliferate, they release proinflammatory products which is associated with
tissue hypertrophy and increased vascularity. The bone turnover in the subchondral bone
is increased, vascular invasion follows which stems from the subchondral bone into
cartilage [5].

Figure 2
Pathological Osteoarthritis. The anatomical and pathological differences between a
healthy and arthritic joint. [5]
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Therefore, it is imperative to examine changes to the subchondral bone along with
cartilage to provide explanations of why current treatment procedures are ineffective. One
treatment technique in particular, microfracture, may fail because regenerated tissue will
overlie a thickened subchondral plate. Essentially, it is not a surface level problem but a
chronic problem that roots deep within many tissues of the joint. With this information, it
is crucial to not put sole focus on regenerating articular cartilage, but to target the whole
osteochondral unit for treatment and prevention of osteoarthritis.

4

Chapter 2
Background
2.1 Tissue Engineering
Tissue Engineering (TE), an alternative application to tissue grafting and alloplastic
repair, is achieved through a multidisciplinary approach of various engineering sectors
[12]. The concept of tissue engineering was articulated in detail in 1985 while the first
symposium for tissue engineering was held 1988 [13]–[17]. TE and regenerative medicine
are gathering much attention and are becoming a focal point in the scientific community of
research. This field seeks to restore damaged or diseased tissue and restore and improve
their function by developing biomaterials for the task [14], [15], [18]–[20]. An approach
to practice TE is incorporating cells and/or bioactive molecules into biodegradable
scaffolds to replace the damaged natural tissue [21].

5

Figure 3
Tissue Engineering. Tissue engineering uses raw Materials in form of cells,
biomaterials/scaffolds, and a combination with environmental factors to create engineered
tissues [22].

2.2 Musculoskeletal Engineering
One of the many subfields of TE is musculoskeletal tissue engineering (MTE)
which concentrates on replacing the damaged tissues related to the musculoskeletal system
such as bones, cartilage, muscles, and more [23], [24]. Biomaterial scaffolds are one of the
main elements in this field and they are designed to work parallel to cells, environmental
factors and signaling molecules which all have a significant effect on the success of the
material and engineering aspect [13]. Cartilage and bone have been a main area of interest
in musculoskeletal tissue engineering because of the challenges they present. However,
cartilage presents a bigger challenge because it is avascular and unlike bone, cartilage
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cannot be self-healed. This in conjunction with a life of wear and tear on the joint leads to
the degeneration of the cartilage and osteoarthritis.
2.2.1 Mesenchymal Stem Cells
One of the most used cells in the subfield of MTE are mesenchymal stem cells
(MSCs) which are multipotent stem cells that can differentiate into several musculoskeletal
lineages such as osteoblasts (bone cells), chondrocytes (cartilage cells), and myocytes
(muscle cells) [25]. MSCs are the most suitable cells for this work as they are able to be
guided into differentiating into resident cells of numerous connective tissues including fat,
bone, and cartilage [22]. Figure 4 shows MSC lineage types.

Figure 4
MSC Lineages. [26]

7

2.2.2 Cell Matrix Interactions
MSC interactions with engineered environments that recapitulate key features of
the native extracellular matrix (ECM) has been considered a major aspect of tissue
engineering, with the goal of creating biomaterials that act as substitutes for damaged
tissues [17], [27]. The ECM is created by cells as they secrete molecules that in return build
the surrounding structural and biochemical support. To further understand development of
functional tissues through engineering, it is important to research the ECMs chemical and
physical properties. To recapitulate and engineer cell environments, the understanding of
ECMs gives rise to the design of artificial ECM in structures known as scaffolds [13]
Different tissue types have unique ECM compositions depending on the functional
and biological requirements of that tissue. The most abundant fibrous protein within ECM
is collagen as it provides the structural support of tissues and attachment of proteoglycans.
There are 28 different types of collagens with fibrillar collagen being the most prevalent in
the body. However, depending on the tissue function, collagen composition varies
throughout tissues. On the other hand, glycosaminoglycans or GAGs are long unbranched
polysaccharides and an important ECM component in all tissue types. GAGs function to
provide structural support and help maintain healthy tissue by protecting and preserving
ECM proteins and cytokines when they attach to proteoglycans, adhesive glycoproteins,
and fibrous proteins [28], [29]. This information is crucial to understand because the type
of cells, GAGs, proteoglycans, and proteins present determine the characteristics of the
tissue [13].
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The complexity of ECM environments and the requirements needed to replicate
them are case dependent and vary greatly. For instance, this intricacy is observed upon
inspection of the articular cartilage environment. Relevant to this work, are the zonal
differences of ECM in articular cartilage. It is anisotropic in nature and can be classified as
having three architectural zones. In Figure 5 the zones of articular cartilage are shown.
These zones are the superficial, middle, and deep zone and have striking differences
between their composition with reference to structure, chondrocyte phenotype, and
mechanical properties [30]–[32]. Chondrocytes are elongated in the superficial zone due
to the highly packed collagen fibers which are parallel to the surface to dissipate tensile
strength and have a lower concentration of proteoglycans [31], [33].

Figure 5
Articular Cartilage. The organization of chondrocytes and collagen fibers in articular
cartilage [13].
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Rounded chondrocytes reside in the middle zone with a random collagen fiber
orientation to strengthen the unpredictable compressive force that will be dispersed to this
zone [31], [34]. The deep zone contains the necessary shape and morphology of
chondrocytes to provide the cartilage with high compressive stress resistance. This natural
design constraint results in the chondrocytes to be stacked in columns with radial collagen
architecture and high proteoglycan concentration [31], [33].

Figure 6
Cartilage Types. Histological differences between hyaline, fibrocartilage, and elastic
cartilage [13].

2.3 Mechanobiology
Understanding how cells interact with the environment via mechanics is referenced
as mechanobiology. This space focuses on how physical forces and changes in the
10

mechanical environment change cellular function, differentiation, and morphology. The
ECM is a highly dynamic 3D structure where cells interact with a myriad of biophysical
and biochemical cues that can direct their cell lineage and function. Mechanical stimulation
can dictate cell response through the modification of the cytoskeletal which leads to cellmatrix interaction and provides intracellular biochemical responses [35],[36]. For instance,
the stiffness and fiber alignment highly influence the cellular function (i.e. morphology
and

mechanosensing/mechanotransduction)

and

differentiation

[37]–[39].

Mechanotransduction is the ability of the cells to converse the biophysical cues from the
matrix into chemical or biological signals [40]. Mechanosensing is the capacity of a cell to
sense mechanical cues (e.g., matrix stiffness) from its environment [41]. Furthermore,
work has been done by Chen et al., displaying environmental physical factors can result in
cell shape differences.
The lab proved with biopotential media in combination with osteogenic media,
when cells were in restricted environments, they were large and spread and eventually
differentiated into osteoblasts. They mentioned a Rho, ROCK, tension, signaling pathway
and attributed osteogenic lineage with the tension experienced from the restrictive
environment [35]. The aforementioned cell properties can be determined by analyzing the
localization of the Hippo pathway Yes-associated Protein 1 (YAP), and Transcriptional
coactivator with PDZ-binding motif (TAZ) which are considered the primary sensors of
the cell’s physical nature and will diffuse into the nucleus [27], [39], [40], [42]. Cellular
morphology and mechanosensing can be altered by varying dimensionality of a biomaterial
[41], [43]. Buxboim et al., showed that cells can sense the effective stiffness of rigid objects
that are not in direct cellular contact. The group concluded cells can increasingly respond
11

to the rigidity of an underling surface and sense the stiffer material [44]. An example of
how cell stiffness and traction force influences cell lineage and morphology is shown in
Figure 7. Furthermore, Subramoney et al., proved that when MSCs were in an aligned
matrix while sensing mechanical stimulation, they differentiated into ligament fibroblastlike cells. However, in an unaligned environment, its attachment morphology changed [38].

Figure 7
Cell Morphology. Morphological cell response to material stiffness [26].

2.4 Knee Joint
The knee is the largest joint in the body. It is a synovial joint where the femur and
tibia meet and are connected by ligaments and paired with cartilage to create a cushioned,
stable, frictionless interface (Figure 8) [45], [46].
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Figure 8
The Knee Joint. Simplistic biological view of the knee joint.

The ligaments that connect the femur to the tibia and provide joint stability include
the anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), medial collateral
ligament (MCL), lateral collateral ligament (LCL), and antero lateral ligament (ALL). The
ACL and PCL primary purpose is to prevent movement of the joint forward or backward
and the MCL and LCL provide stability against lateral movement.

Figure 9
The Knee Joint Components. A) Articular cartilage composed of hyaline cartilage lines the
condyle of tibia and fibula. B) The stabilizing ligaments of the knee. C) The menisci which
act as shock absorbers. [47]
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Articular cartilage covers the surfaces of the bones including where the femur meets
the tibia and has important functions. It is highly specialized connective tissue found at the
epiphyses of synovial joints and 2-4 mm thick referenced in Figure 9[47]. This cartilage’s
purpose is to protect the underlying subchondral bone and is composed of hyaline cartilage
which in combination with synovial fluid, minimizes the frictions between movable joints.
This cartilage also acts as a shock absorber and helps redistribute the shear forces and loads
of everyday movements evenly throughout joints.
Another major component of the knee joint are the menisci. The menisci reduce
shock and absorb the impact distributed to the joint when the bones move or bear weight.
They function as the primary cushion, shock absorber, and first layer of defense for
articular cartilage integrity [1]. Maintaining the integrity of the articular cartilage is crucial
in the preservation of the joint and entire bone cartilage interface.
2.5 The Osteochondral Interface
The interface where bone meets cartilage is referred to as the osteochondral
interface comprising of articular cartilage and subchondral bone [48]. Osteochondral tissues
are multilayered and heterogenous consisting of a high concentration of osteoblasts in the
underlying bone which merges in a gradient like fashion with chondrocytes in the cartilage
lining the bone. This unit consists of mineralized and highly vascularized subchondral bone
layer, an articular cartilage later that is acellular and avascular, and between bone and
cartilage exists a gradient tissue layer with biochemical and physical properties [49]. The
osteochondral unit is shown in Figure 10 [50].
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Figure 10
Osteochondral Tissue. A) The layers of osteochondral tissue. B) A representation of the
osteochondral interface where cartilage and bone meet and there is a gradient of
osteoblasts and chondrocytes.

Damage in natural osteochondral tissue i.e., a defect or lesion, can lead to
osteoarthritis initiating matrix degradation and implies the need for engineering synthetic
osteochondral tissue as a treatment of the disease [50]. Injury to orthopedic tissues is highly
prevalent as the demand for primary knee arthroplasties is projected to increase to over 3.4
million procedures by 2030 [51]. These osteochondral injuries/defects produce a
significant burden around the world as there are hundreds of thousands of surgical
procedures performed annually [52]. It has been cited osteochondral defects can be found
in more than 60% of patients undergoing knee arthroplasty [52]. This statistic is a result of
different factors including trauma, tumors, infections, and the progressive aging of the
world population. For instance, people affected from these misfortunes develop bone and
joint diseases which cause them to endure suffering for years to come [13]. Furthermore,
15

osteoarthritis is on the increase due to the multitude of mentioned factors and is expected
to affect two billion people by 2050[53]. Therefore, it is important to continue research in
this field and help relieve the burden osteochondral defects will cause on a significant
population of the world.
2.6 The Goal of This Work
The main objective of this work is to develop a mechanically stiff environment that
recapitulates the gradient tissue zones in the osteochondral interface. The general focus is
to observe the morphological differences between MSCs as they are exposed to varying
mechanical forces created by a composite biomaterial. The composite will be fabricated
using salt leach method to create a porous stiff polycaprolactone backbone. The PCL
provides a 2D environment and the force necessary to create a stress gradient of an injected
hydrogel. This hydrogel will be synthesized using methacrylate gelatin and UV light for
the purpose of a softer 3D environment inducing spread and round morphologies of cells.
Biophysical signals including dimensionality and stiffness have been shown to influence
cell behavior including mechanosensing, morphology and differentiation. The goal of this
study is to create a composite that integrates these divergent biophysical signals within one
system. The two separate environments will coexist inside the composite allowing for
heterogeneous cell morphologies based on location of the cell in the pore. Through this
work it is shown cells in the composite not only exhibit differences in morphology and
mechanosensing than cells in gel alone, but they display differences based on pore
diameter. The composite is currently being researched for the osteochondral tissue
interface to provide an avenue exposing cells to varying biophysical forces like those
presented in native tissues.
16

Chapter 3
Treatment Methods and Fabrication Techniques – A Review
3.1 Introduction
The complex structure and function of articular cartilage is prone to injury, it can
be disrupted by everyday activities, and the response varies depending on the severity and
depth of injury [4]. Response of superficial injuries can be as trivial as a disruption to the
surface level cells or could initiate a cascade toward degeneration of the surface that are
not visible. However, cartilage is susceptible to macro disruption when the injuries are
more severe and can result in chondral fissures or partial thickness loss. The most severe
case of injury occurs when the subchondral bone is immediately affected which can result
in full thickness injury and osteochondral fracture [4]. As damage occurs, it results in
limited metabolic capacity for repair of chondrocytes and a decrease in proteoglycan
concentration. In turn, this causes decreased cartilage stiffness, and increased hydraulic
permeability which directly results in increased force transmission to the underlying
subchondral bone [54]–[57]. The increase of force causes an increase in stiffness of the
bone and transmits the loads of impact back to the damaged cartilage thus, resulting in
multifactorial tissue complex involvement and more articular cartilage injury that is caused
from stiffening of the subchondral bone [58]. These injuries, responses, articular cartilage’s
avascular nature, and its inability to properly heal itself are examples of how osteoarthritis
is such a prevalent condition and is consistently a problem for orthopedics. To treat these
injuries a variety of techniques are used without much regenerative efficacy.
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Current scaffolds on the market like the traditional techniques of monolayer
scaffolds and injectable hydrogels often fall short of replicating spatial patterning of
biochemical cues in native osteochondral tissue. This evokes the question; what type of
treatment is there for these lesions to prevent osteoarthritis? Below are mentioned some of
the current treatments for lesions and chondral defects.
3.2 Cartilage Techniques
3.2.1 Arthroscopic Lavage and Debridement
Debridement is usually the first level of chondral injury treatment [4]. This is done
to reduce mechanical symptoms and inflammation however, there is no standalone
evidence this technique helps restore cartilage or has long term benefits other than
immediate pain relief [59]. This technique combined with lavage has shown benefits but
only in patients with a specific history minimum cartilage damage [60].
3.2.2 Microfracture
Microfracture is a common technique used to stimulate the production of cartilage.
Microfracture is a reproducible, atraumatic method that consists of creating 1-2 mm
diameter holes in underlying cancellous bone releasing blood and to recruit bone marrow
MSCs to restore the cartilage within a carefully prepared lesion (Figure 11) [4], [61], [62].
However, the main caveat of this method is that it generates a cartilage that resembles
fibrocartilage which is mechanically inferior to hyaline cartilage [63], [64]. A study
showed deterioration is present in the joint within 18-24 months post microfracture surgery
and deterioration is greater when trying to treat a large defect [64]The results can be even
less effective due to poor patient compliance as the procedure requires patients to be non18

weight bearing for at least 6 weeks [61]. This method is considered the gold standard for
cartilage repair even with reports the fill of the chondral defect is rarely over 75% [65].

Figure 11
Microfracture. [66]

3.2.3 Osteochondral Autograft
Osteochondral autographs involve the transfer of intact hyaline cartilage and
subchondral bone otherwise called a bone plug, and they heal to the surround recipient
tissue [62], [67], [68]. The osteochondral autograph is removed from non-weight bearing
areas of the knee and is transferred to the chondral defect to produce chondrocytes and
maintain the extracellular matrix with load bearing capacity (Figure 12) [69]. As with all
techniques, it has benefits and contraindications. This procedure is limited by donor tissue
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available in the knee and has certain ideal indications. Symptomatic distal femoral condyle
articular cartilage lesions with intact menisci and tibial cartilage with proper mechanical
alignment in a non-degenerative joint is the ideal indication of this technique [61]. The
drawbacks and limitations of autograph transfer include ideal lesion size of 1 to 2 cm in
diameter, risk of donor site morbidity, fibrous tissue formation, intensive transfer
procedure, and limited graph volume [67], [70].

Figure 12
Osteochondral Autograph. [13]

3.2.4 Osteochondral Allograft
This technique is employed when larger constructs are necessary and harvested
from cadavers [4]. It allows for bigger lesion treatment and with no concern for donor site
morbidity [61]. Osteochondral allograft has different limitations than autograft methods
mentioned previously as it is not suitable in lesions caused by diffuse disease processes
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like osteoarthritis, graft ability, cell viability, immunogenicity, and disease transmission
risks [61]. However, if avascular necrosis is localized and the rest of the bone is healthy,
this procedure may be explored and with a higher positive outcome chance with lower age
[4].

Figure 13
Osteochondral Allograft. [71]

3.2.5 Autologous Chondrocyte Implantation (ACI)
Autologous chondrocyte implantation is a cartilage regeneration technique that
includes a two-step surgical process. The process includes surgery that harvests hyaline
cartilage from a low weight bearing region of the knee followed by in vitro expansion of
chondrocytes and then a second surgery to implant the expanded cells into the defect
location shown in Figure 14 [4], [13]. ACI is ideal when first line treatments fail and when
osteochondral defects measure 2 to 10 cm2, are unipolar, and well contained [61]. The
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contraindications include are similar with those mentioned before. Bipolar lesions,
malalignment, ligament instability, and meniscus deficiency are also obstacles that hinder
ACI outcome [61]. ACI has shown more positive results than microfracture when defects
are larger but there is not significant data to validate better results when the defects are
small[72]–[74]. Also, the two-step surgical process is difficult for patients as the entire
process has a recovery time of 6-12 months [75]. ACI has shown fibrocartilage formation
in conjunction with hyaline cartilage which may be attributed to the 2-D culture in vitro on
tissue plates and without mechanical stimulation. Meanwhile, the 3D structure of in vivo
tissues coupled with mechanical loading induces the correct tissue formation without
phenotype drift [13], [76].

Figure 14
ACI. Two step surgical process of ACI and MACI [13].
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3.2.6 Matrix-Assisted Chondrocyte Implantation (MACI)
Matrix-assisted chondrocyte implantation (MACI) is the second generation of ACI.
MACI has an almost identical process to ACI which is depicted in Figure 15. However,
the expanded chondrocytes are seeded onto a collagen membrane scaffold before the
reimplantation not injected back into the debrided site at random. MACI uses the matrix to
help defect filling by localizing the implanted cells at the location of defect and has been
shown to have less incidence of hypertrophy when compared with ACI [13], [77]. Also,
grafting techniques are recommended for defects of more than 8 to 10 mm in depth as this
method does not provide subchondral bone development [61].

Figure 15
MACI. Matrix-assisted chondrocyte implantation schematic [13].
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3.2.7 Treatments Overview
Articular cartilage is complex and highly specialized and therefore is difficult to
reproduce [4]. Recent advancements in MTE have allowed properly selected patients
options for cartilage and osteochondral repair. The problem lies in the techniques used to
replace the articular cartilage. MACI is the only FDA approved treatment for articular
cartilage defects using a biomaterial scaffold and yet it neglects the underlying issue of the
entire osteochondral interface which may only mask the problem of further degeneration
of the joint along with fibrocartilage formation. The challenge remains to make a treatment
option for osteochondral repair of those patients who do not fit the selectiveness or fit as
candidates of the above techniques. A summary of the surgical techniques to try and fix
osteochondral defects and lesions is shown in Figure 16.

Figure 16
Treatment Overview. Overlapping treatment options from palliative, to reparative, to
partial restorative [4].
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3.3 Scaffolds for Tissue Engineering
3.3.1 Introduction
Fabrication and design of biomaterials are major areas of research and important
for the growth and development of tissue engineering and regenerative medicine. Kumar
et al., defines scaffolds to be three dimensional porous solid biomaterials that are designed
for multiple functions [78]. Generally, scaffolds serve the purpose of structural support and
templates for tissue engineering and are composed of natural or synthetic polymers or even
a combination of engineered and natural materials (Figure 17). There have been many
scaffolds created and used for tissue engineering purposes in the past. Four general
purposes for scaffolds include: (1) promote cell and biomaterial interactions, ECM
deposition, and cellular adhesion, (2) allow passage of nutrients, regulatory factors, and
proliferation and differentiation, (3) appropriate biodegradability, and (4) be bioinert and
biocompatible.
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Figure 17
Biomaterial Classification. [13]

3.3.2 Biomaterials
Depending on the intended use of the scaffold the materials can be synthetic or
biologic, degradable or nondegradable [79]. These scaffolds can have two major origins in
which they are classified including biological scaffolds that are derived from human or
animal tissues, and synthetic scaffolds which are fabricated from polymers, metals,
ceramics, and glass [80]. Scaffolds are fabricated and designed for different applications.
For example, bone tissue engineering requires a mechanically superior scaffold than one
designed for cartilage engineering and may require 2D dimensionality while cartilage
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requires 3D dimensionality. Synthetic bioresorbable polymers for bone and cartilage tissue
engineering include PCL, PLLA, poly(glycolic acid) (PGA), and polyvinyl alcohol (PVA)
provide mechanic stability and can be formulated as either hydrogels, solids, or fibrous
constructs. The two major categories are enticing for researchers for their different roles.
3.3.2.1 Synthetic Materials. A synthetic scaffold can be hard, stiff, but lack the
biophysical and biochemical ques present in the native ECM. However, synthetic scaffolds
may provide optimal characteristics such as rate of degradation, porosity, microstructure,
strength, availability, and reproducibility. Porous premade scaffolds can be fabricated
using synthetic materials. To improve bioactivity of the scaffold as coatings or surface
modifications polysaccharides (chitosan, alginate, agarose), protein-based materials
(collagen, gelatin, and fibrin), and glycosaminoglycans (hyaluronic acid and chondroitin
sulfate), can be included in the fabrication process of the hard polymers [81], [82].
Therefore, PLA, PGA, and PCL are interesting materials due to their high elastic
performance and strength for bone soft tissue scaffolds.
3.3.2.2 Natural Materials. Biological scaffolds that are decellularized may lack
the mechanical toughness required to withstand the loads necessary for success, but they
can generate less of an immune response and allow for appropriate ECM production.
Scaffolds can be made from decellularized ECM from allogenic or xenogeneic tissues
(biological), cell encapsulation in self-assembled hydrogel, or other natural materials [83].
As natural biomaterials lack mechanical stability, it is necessary to explore the
spectrum of synthetic biomaterials. Synthetic scaffolds have great appeal to this work as
the goal of this thesis was to create a construct with comparable mechanical stability as the
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osteochondral interface. Synthetic biomaterials allow for development of stronger
scaffolds with shape and architecture of native tissue. Synthetics offer high reproducibility
and mechanics, but they present poor bioactivity in terms of hydrophilicity and cellular
interaction cites when compared against natural materials [84]. One of the most used
materials in scaffold fabrication and extremely relevant to this work is polycaprolactone
(PCL) which has been used for tissue engineering applications since the 1930s [84]. Other
common materials include poly(L-lactic acid) PLLA and poly (lactic-co-glycotic) acid
(PLGA).
3.3.3 Scaffold Fabrication Techniques
As previously mentioned, scaffolds for tissue engineering are common and
increasing in practice for the regeneration of all tissue types. Materials of biological and
nonbiological origin have been used as early as the Neolithic period and sutures may have
been used long before that[85]. A timeline of biomaterial applications in the history of
recorded time is shown below in Figure 18. In this era of time, there are constraints and
design criteria when recreating the OI which encourages a successful scaffold. The
elementary first step is to use a biocompatible biomaterial that does not elicit any response
from the host. Biodegradability is next as it is crucial to allow cells the opportunity to
produce their own ECM. Another important consideration is one must know the
mechanical environment of the tissue the scaffold is mimicking as it must perform the
mechanical function of the native tissue. In this case, there is a very stiff environment, the
underlying bone, and a softer environment, articular cartilage. Scaffold architecture, design
of biological interface, and what the purpose the scaffold serves are other concerns that
must be reflected in design [13]. The development of biomaterials and fabrication methods
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has fostered novel techniques and increasing complex environments for regeneration and
repair of tissues. Fabrication methods for porous, hydrogels, decellularized, and bioprinted
scaffolds are described in detail below.

Figure 18
Timeline of Biomaterials. View of how biomaterials progressed as technological
advancements have been made [13].

3.3.3.1 Porous Scaffolds. Porous scaffolds provide an environment suitable for
injection of cells and are an avenue of treatment with regards to disorders and diseases.
These scaffolds can be composed of natural or synthetic materials or can be a combination
of the two materials which creates a composite [86]. These porous biomaterials can be
fabricated using techniques mentioned by Chan et. al like 3D printing, salt leach method,
and stereolithography [83]. The next few subsections will provide techniques on how to
create scaffolds and their pros and cons. For example, scaffolds can be produced using
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methods of electrospinning, but this technique creates a lack of compressive strength [87],
[88].
3.3.3.1.1 Solvent Casting and Porogen Leaching (SCPL). Solvent casting and
porogen leaching (SCPL) includes a simple, reproducible technique that requires two main
steps. First, the solid is dissolved in a solvent mixed with an insoluble porogen which is
typically NaCl, sugar, or other particles followed by casting the mixture and evaporating
the solvent to produce a solid consisting of polymer and porogen [13]. The porogen is
leached out of the construct by submerging it in an aqueous solution to yield an
interconnected pore network throughout the solid (Figure 19). A benefit of this technique
is its simplicity and tunability in terms of pore size, shape, and uniformity within the
structure.

Figure 19
Solvent Casting. Schematic depicting the steps in sequential detail of the fabrication
process for solvent casting and porogen casting [13].
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3.3.3.1.2 Phase Separation. Phase separation is a technique that can be used to
create scaffolds. However, as pore size usually is less than 200 µm the application for tissue
engineering is limited. In this process a homogeneous polymer solution separates into
polymer rich and polymer poor phases when it becomes thermodynamically unstable by
cooling the solution below the solvents freezing point to initiate crystal nucleation and
drives phase separation. After completely frozen the solid material is sublimed which
removes the solvent and leaving the polymer rich regions forming scaffold walls and the
polymer poor regions yield the pores.
3.3.3.1.3 Gas Foaming. Gas foaming technique relies on a blowing agent which
generates gas bubbles in a solid polymeric sample, leading to pores. This technique is
advantageous as it does not rely on use of porogens and solvents however, controlling pore
size, uniformity and reproducibility remains challenging.
3.3.3.1.4 Sintering. The sintering technique bonds together polymer and ceramics
into a porous scaffold. This process includes heating a bed of particles above the base
material transition temperature but below its melting point to encourage diffusion of
molecules on the surface of the beads toward the contact point of the particles to fuse them
together and produce a porous structure. These scaffolds usually have lower porosity and
smaller pores than scaffolds produced by other methods [89].
3.3.3.1.5 Electrospinning. Electrospinning (ES) is the most widely studied
fabrication process in the field of TE [90]. Electrostatic principle is the governing theory
in which the electrospinning process works. The depiction below (Figure 20) shows an
overview of the process. It relies on an electric field generated between a polymer solution
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and a collector which draws the solution into a fiber. A syringe with a nozzle, a counter
electrode, electric field source and a pump compose the necessary elements of the process.
To start the process, the solution to be electrospun is loaded into the syringe and is pulsed
by the pump. Then the solution is exposed to the difference in electrical voltage between
the nozzle and counter electrode which generates a charge on the polymer solution and
results in a cone shaped deformation of the drop of polymer solution. As the solution makes
its way to the counter electrode, the solvent evaporates and produces a continuous solid
filament [91]. Fiber diameter can be controlled by polymer concentration, solvent
selection, flowrate, needle dimensions, and voltage differential and distance between the
needle and collector.
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Figure 20
Electrospinning. A) A forward view of the process where the polymer is projected onto the
counter electrode. B) A side view of the electrospinning process [91].

3.3.3.2 Hydrogels. Hydrogels are another class of biomaterials that have been
widely explored in 3D as they can mimic the natural extracellular matrix (ECM) including
the degradation of the surrounding which allows for remodeling of tissue [92], [93]. They
are crosslinked 3-D networks of hydrophilic polymers that can hold and absorb large
quantities of water. The benefits of hydrogels are many and their porous and swollen
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polymer network allows for nutrients and cell waste to diffuse through the material. These
provide a unique way to encapsulate cells within a membrane for specific purposes.
Hydrogels are formed by covalent or ionic cross-linking of water-soluble polymers and are
one of the best candidates for encapsulation [83]. A GelMe hydrogel fabrication process is
shown in Figure 21. Although this approach has weaknesses like poor mechanical
properties, it has appealing characteristics as it is minimally invasive, useful for a defect
with abnormal shape, and degradable by the cell. The stiffness can be tuned by changing
the wt % of the macromer. They can be synthesized from natural biopolymers, synthetic
polymers, or a combination of them and the most common used materials include, collagen,
elastin, fibrin, hyaluronan, chondroitin sulfate, gelatin, and many others. Hydrogels
provide benefits as they have low cytotoxicity and can modulate cell responses like
attachment, proliferation, and differentiation.

Figure 21
GelMe Hydrogel Fabrication. [83]
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3.3.3.3 Tissue/Organ Decellularization. Decellularized ECM scaffolds for cell
seeding have gained popularity in designing scaffolds for tissue engineering applications.
The advantages of using these scaffolds include they are biocompatible and have almost
minimum to no immune response from the host and the resultant ECM is designed to
provide cells in a 3D environment [94]. To create the immuno-friendly scaffold with just
natural ECM remaining, detergents or enzymes must be used [94], [95]. To decellularize
tissue there are physical, chemical, and or enzymatic protocols. Physical protocols include
disrupting the cell membrane and using sonication, freezing, or mechanical force use. To
remove via chemically, detergents, acids, bases, chelating agents, hypotonic and
hypertonic solutions or of enzymes can be used to remove cellular debris. However,
decellularized ECM scaffolds for cell seeding usually lack mechanical properties necessary
to create a construct strong enough to bear mechanical loading equivalent to joint tissue.
3.3.3.4 Tissue Bioprinting. There are a few different approaches when considering
bioprinting and tissue bioprinting is a rapidly emerging fabrication method for scaffolds in
musculoskeletal tissue engineering. A generalized sequential process for tissue bioprinting
is shown in Figure 22. The following subsections will give a brief overview of some 3D
printing techniques.
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Figure 22
General Bioprinting Process. [13]

3.3.3.4.1 Powder-bed 3-D Printing. There is powder-bed 3-D printing which relies
on the selective spatial delivery of a binder onto a powder bed by an inkjet printer. This
process uses sequential application of powder layers intersperse by addition of the binder
and a drying step to create 3D structures. The structure is supported as it is built by the
uncoated lose powder bed. This is followed by removing the loose powder and sintering
the powder particles together providing mechanical integrity to the structure. The powder
properties control the resolution of this technique as well as the printer technology. This
process can allow for generation of scaffold gradients in the z-axis via changes of the
powder bed [96]. However, a limitation of this technique is it suffers from construct
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shrinkage and deformation during the sintering step, and it is difficult to make pores smaller
than 600 µm because of the strayed loose powder [97].
3.3.3.4.2 Selective Laser Sintering (SLS). Selective laser sintering (SLS) is a similar
process to powder-bed 3-D printing however, the powder particles are sintered directly in
the powder bed rather than bound with a binder and sintered later.
3.3.3.4.3 Fused Deposition Modeling. Fused deposition modeling (FDM) is an
example of melt extrusion-based technique. A computer aided design (CAD) model
dictates spatial coordinates whereby a polymer extruded by a heating nozzle by which it is
melted [13]. This process can become very intricated as multiple extrusion nozzles can be
used to apply the polymer that acts as temporary support while creating compositional
gradients in three axes.
3.3.3.4.4 Stereolithography. Stereolithography (SLA) creates a 3D structure and
uses computer-controlled laser beam or ultraviolet light to polymerize a photocurable
liquid monomer film in a spatially selective manner (Figure 23). The uncured polymer is
removed to reveal the intended structure and can be further polymerized to increase the
bonding and mechanics of the scaffold. As the base material typically is introduced as
liquid, SLA is not easily amenable to changes in the construct composition across its depth.
It allows the fabrication of parts from a computer aided design file. The external and
internal pore geometry can be devised using 3d computer drawing software, mathematical
equations, or from scanning data like MRI [13]. The structure can be fabricated by
uploading the data to the SLA apparatus which makes the biomedical fabrication of this
method enticing.
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Figure 23
Stereolithography Process Overview. [13]

3.4 Conclusions
We proposed the formation of a composite biomaterial made of a 2D rigid material
(PCL) and a 3D elastic one (GelMe hydrogel). It is hypothesized this mixture may cause
heterogeneity in the cellular environment with varying dimensionality and stress.
Additionally, we hypothesized that the PCL scaffold will cause mechanical stimulation and
stress loading on the cell-encapsulated hydrogel due to the large differences in Young’s
modulus leading to a stress gradient within the hydrogel pore region of the composite and
that the cell can sense this gradient which will impact cellular morphology [44]. The cell
remodeling phases and MSC morphology changes to different compressive loading will be
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explored. This composite will be crucial in TE application since it can replace damaged
interfaces such as osteochondral interface (OI), located between bone and cartilage due to
the mechanical adaptation of MSC to the different environment [48][50].
The synthetic OI will be crucial in preventing osteoarthritis specifically in the knee
joint between femur and tibia which could eventually reduce the large increase of demand
for primary knee arthroplasty[51] [45], [46], [98]. Even though the effect of dimensionality
and remodeling on cellular behavior has been widely studied, to this date, there have been
no engineered materials combining the effects of dimensionality and remodeling properties
to investigate cell-material interactions. This combined scaffold could be useful for
creating tissue substitutes such as an osteochondral interface located in the knee.
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Chapter 4
Studying Bulk Compression vs. Cellular Remodeling
4.1 Introduction to Environmental Factors
Dimensionality and mechanical stimulation are important factors that can influence
MSC mechanical behavior. Depending on the dimensionality of the substrate, cells can
vary in their response to the matrix stiffness. MSCs cultured in 2D rigid material are large,
spread, and YAP localized in the nucleus [43], [99]–[101]. Meanwhile, in 2D, MSCs can
only differentiate into osteoblasts if seeded in 2D rigid materials and exposed to the bone
morphogenetic protein 2 (BMP2) [102][102]. Polycaprolactone (PCL) porous scaffold can
be fabricated to encompass stiff characteristics and qualities that are used in TE. As PCL
can be fabricated to be very stiff, degrade over time, and biocompatible, it can mechanically
mimic the properties of bone [103]–[107].
It is also important to note articular chondrocytes have shown dramatic morphology
changes as they have demonstrated spreading when cultured on 2D monolayers from the
smooth elliptical shapes of chondrocytes found in normal articular cartilage [108]. On the
other hand, MSCs have an alternate mechanical response when encapsulated in soft 3D
biomaterials such as hydrogels. MSCs encapsulated in the 3D elastic hydrogel can be
smaller, have their YAP/TAZ localized in the cytoplasm, and be round in morphology
which encourages MSC chondrogenesis [104]. It has been discovered by Mcbeath et al.,
cell spreading regulates stem cell differentiation. Environments that favor a spread shape
help MSCs differentiate into osteoblasts and environments that favor a round shape help

40

MSCs differentiate into chondrocytes (Figure 24) [26]. Therefore, an objective of this work
was to engineer an environment that allowed a co-population of spread and round MSCs.

Figure 24
Environmental Morphology Differences. [108] Cell’s cytoskeleton stained red on a stiff
substrate with spread morphology help cells differentiate into osteoblasts. Cells stained in
magenta encapsulated in a 3D environment and with round morphology will help cells
differentiate into chondrocytes.

4.1.1 Cellular Remodeling
Cellular remodeling plays a crucial role in cellular behavior because it can lead to
differentiation, morphological changes, migration, and proliferation [93], [109], [110]. A
result of this finding emphasizes the importance to synthesize a hydrogel that can degrade
over time [110]–[112]. During the remodeling phase, cells exhibit normal spreading while
having YAP/TAZ localized in the nucleus [113]. A degradable hydrogel can either be

41

formed by incorporating protease-degradable crosslinker such as Hyaluronic Acid
modified with norbornene or by means of incorporating a biodegradable backbone such as
Gelatin [114]–[116]. Methacrylated gelatin (GelMe) hydrogel contains a gelatin backbone
and degrades at the presence of matrix metalloproteinases (MMP). MMP is secreted by
cells during the remodel process leading into the localization of YAP/TAZ in the nucleus
[36], [117].
4.2 Methods
4.2.1 GelMe Macromer Synthesis
Methacrylated gelatin was synthesized using the technique described previously
[118]–[120]. Gelatin was mixed in PBS at 10% (w-to-v) at a temperature of 50 °C and a
speed of 1200 rpm for 20 minutes. Then 1.74 ml of methacrylate anhydride was added
dropwise into the GelMe solution and stirred for one hour under the constant nonvarying
speed and consistent temperature without exposure to room air. Once completed, the
GelMe solution was centrifuged to remove the supernatant and then mixed with prewarmed
PBS. GelMe was dialyzed to further purify it for 5 days followed by a lyophilization
process to remove any excess water and kept in a -20 °C freezer until needed then analyzed
in H NMR.
4.2.2 PDMS Mold
Polydimethylsiloxane (PDMS) mold was synthesized to support the formation of
the cylindrical hydrogel. Sylgard 184 (Electron Microscopy Sciences) was mixed with the
curing agent at a 3:1 ratio. Next, the mold was desiccated to remove all air bubbles and
then was baked in the oven at the temperature of 80 0C for 1 hour. The mold then dried at
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room temperature for 45 minutes. After completely drying and before hydrogel formation,
the PDMS mold was punched by an 8 mm biopsy to have an 8 mm opening for the GelMe
solution. The mold was cut and adhered to the thiolated coverslip using silicon as a binding
agent.
4.2.3 Coverslip Thiolation
Necessary to synthesize gel and ensure a defined location, thiolated coverslips were
assembled. Coupling the gel into the coverslip required several steps. First, coverslips were
placed in a sodium hydroxide solution (NaOH) for 20 minutes. Next, it was re-submerged
in for another 10 minutes in the same solution. After washing the coverslips twice, they
were submerged inside of the thiolated solution (83% of toluene, 4% hexylamine, and 13%
of silane) for one hour followed by two Toluene washes. Finally, the coverslips must be
baked in the oven for one hour at 110 0C.
4.2.4 H NMR
After synthesizing GelMe macromer, the polymer was analyzed in H NMR to
investigate its structure. Peaks represented between 5 and 6 particles per million (ppm)
represent the structure of the methacrylate vinyl group and the one represented after 7 ppm
represents the aromatic side of gelatin.
4.2.5 Mechanical Testing of GelMe Hydrogels
The Young’s Modulus of GelMe was calculated. 5 wt% of GelMe mixed with PBS,
2mM Arginine-Glycine-Aspartate (RGD), and 0.05wt% I2959 was injected onto a
thiolated coverslip adhered with PDMS mold and biopsied in the middle. RGD is included
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as it is one of the most effective peptide sequences for stimulating cell adhesion on artificial
surfaces [1]. The solution was exposed to UV light under an intensity of 10 mW/cm 2 for
10 minutes. Once the GelMe hydrogel was formed, it was submerged in PBS overnight
and then the Young’s Modulus was investigated. The hydrogel strain rate was set to
0.1%/min and the Young’s Modulus was calculated between 10 and 20% strain for a
maximum of 30% strain. The Young’s Modulus was calculated between 10 and 20% (n=6).
The Young’s Modulus was found to be 7.2 kPa which can be considered a stiff biomaterial
when comparing to other hydrogels. It is important to understand that the stiffness of the
hydrogel can be manipulated by changing the wt% of GelMe macromer in solution.
4.2.6 Cell Culture
Human Mesenchymal Stem Cells (hMSCs) were purchased from Lonza Company.
The cells were cultured in Dulbecco's Modified Eagle’s Medium with L-glutamine and
with sodium pyruvate mixed with 10% of Fetal Bovine Serum (FBS) and 1% of
Streptomycin/Penicillin. The cells were passage into P2 before use. Sterile technique was
conducted during all experiments involving MSCs. This technique included sterile work
surfaces, all live cell culture was conducted in a sterile cell hood, and all sterile tools.
Sterility of tools and surfaces was achieved with UV light and Ethanol.
4.2.7 Time Point Experiment
MSCs were thawed at P2 and were cultured until 80% confluency was reached. The
cells were passaged then mixed with the GelMe solution with 1,000,000 cells per ml. 100
µl was pipetted of the cell solution in the thiolated coverslip which resided using silicon as
adhesive on the thiolated coverslip. The total solution then was exposed to UV light for 10
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min under the intensity of 10 mW/cm2. Each hydrogel was analyzed at different time points
1, 3, 5 & 7 days for volume, sphericity, and nuclear YAP to study remodeling and
mechanical activity.
4.2.8 Compressive Simulation
To further investigate the impact of the compressive device on cell encapsulated in
GelMe hydrogel. A computational simulation was used using the FEBio program. A
cylindrical model was created mimicking the form of the hydrogel with 8 mm diameter
and 1.6 mm. The density of the GelMe was chosen to be 1.02 g/cm3. The Young’s Modulus
of the model directly mimicked 7 kPa modulus of the hydrogel and a poison ratio of 0.49
showing an elastic type of material. The bottom of the model was chosen to be fixed in x,y,
and z since the GelMe hydrogel was attached to the bottom of a 24 well. Two pressures
were used representing the force applied by the compressive device on the model. 1230 Pa
was chosen to represent 25% of the compressed height of the model and 2370 Pa
represented 50% of the compressed height of the model. These pressures were chosen by
trial-and-error method. Figure 25 shows the FEBio image of the model.
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Figure 25
FEBio Representation of the Hydrogel.

4.2.9 Compression Device Fabrication
The compression device was designed using a sheet, nuts, and bolts of high
molecular weight plastic (HMWP) shown in Figure 26. The device encompassed the 24
well plate and was configured using the schematic of the well plate dish. The construct
consisted of a top and bottom layer of HMWP and two 50.8 mm side pieces, fastened
together using a binding agent and a hinge joint as well as two eye hooks to ensure locking
mechanics were without fault. Twenty-four 12.7 mm diameter holes were drilled through
the top layer of the device allowing for manipulation of the nylon screws. The height of
the module was 50.8 mm, the nylon screws were 6.35 mm in diameter and 76.4 mm in
height.
All practices were conducted using sterile techniques. Cells were mixed in the
GelMe solution of 100 µl at 1,000,000 cells per ml and then pipetted in an 8 mm PDMS
mold and placed on top of a thiolated coverslip. The gel was polymerized, the mold was
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separated from the gel and then the gel was washed and submerged in media. The bolt was
then twisted to ensure the appropriate percent deformation of the gel. Using a hex head
nylon bolt and a digital caliper, the percent of compression was controlled by bolt rotation
where 1/6 of a rotation was equal to 325 µm and the gel height was controlled by the height
of the PDMS mold which was 2.209 mm. The goal was to compare 0% compression, 25%
compression, and 50% compression at a three-day timepoint. For 25%, 50%, deformation,
5

11

the gel was compressed by twisting the bolt 9 24 and 8 12 rotations from the initial contact
with the nut thread. The gels incubated under compression for 3 days before being stained.
The gels were fixed and stained under compression with Phalloidin, PI, and YAP as
mentioned and then imaged under confocal microscopy. The gels were imaged at the edge
of the gel in mm (0,0), (0.5,0), (1,0), (7,0) (7.5,0) (8,0) and the inner region (3,0), (4,0),
(5,0). The results were quantified using volume, sphericity, and YAP expression to
compare with the three-day controlled group under no compression.
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Figure 26
Compression Device. Customized compression device and well plate dimensions.

4.3 Results and Discussion
4.3.1 Cell Remodeling in 5 wt% GelMe Hydrogel
As described above, GelMe hydrogel degrades in the presence of cells. As such,
there is a need to investigate the degradation rate in function of the remodeling. The study
was done on 5 wt% GelMe hydrogels with a Young’s Modulus of 7 kPa. A density of 1
million cells/mL were encapsulated in the hydrogel and was tested for different time points:
1, 3, 5, and 7 days. Cells at early time points 1, and 3 days are presented to be small and
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more rounded. However, the more the cells spend encapsulated in GelMe hydrogel, the
more they begin to degrade their surrounds and spread (Figure 27).

Figure 27
Timepoint Experiment. A) Bar graph with individual points from cells. B) Histogram data
of timepoint experiment. C) Qualification of cell morphology for 1, 3, 5, & 7 days. Cells
analyzed > 50 for each experiment and *p<0.05 is significant.
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Cell remodeling was observed and the time dependent remodeling behavior of the
cells was studied [92], [93], [109]–[111]. When analyzing F-actin, sphericity, and Nuclear
YAP of MSCs in GelMe hydrogel for 1 day, 3 days, 5 days, 7 days, it was determined
MSCs were remodeling their own tissue by increasing their cellular volume, spreading,
and increasing their nuclear YAP expression. Additionally, the cells began to slowly
remodel their native environment of the lone GelMe hydrogel. Caliari et al., discovered the
same this finding of time varying heterogeneity of cell populations when analyzing their
3D hydrogel [113]. After 3 days of encapsulating MSCs in the hydrogel, the cellular
volume increased enough from day 1 by 3000 µm3 and cellular volume was mostly
homogenous for the 3-day time point and cells increased in volume by ~8000 µm3 from
day 3 to day 5 which is considered rapidly faster than 1 to 3 day. Moreover, the cells at 3
days where more spherical and did not exhibit spreading compared to 5 days (0.65 vs.
0.52). The YAP expression shows the cells are sensing their mechanical environment as
they spend more time encapsulated in the hydrogel when 1 day is compared to 3 day (0.9
vs 1.04). Observing histogram results, the environment at 3 day was still considered a
homogeneous environment with larger results than day 1 (5000 µm3 more than day 1, 0.1
sphericity unit less than day 1, and about 0.5 Nuclear YAP more).
After 3 days of encapsulating MSCs in GelMe, it was found that the cellular volume
increased by about 3000 μm3 (5120 μm3 to 8160.56 μm3), sphericity stayed steady, and the
nuclear YAP increased by 15%. Throughout the 4 timepoints cell average volumes are
between 5000 μm3 and 20,000 μm3, sphericity between 0.45 and 0.7, Nuclear YAP
localization between 0.6 and 1.5.
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Taking all these into consideration, encapsulating MSCs in 3 days was the optimal
time point since it represents the time where the cells were starting to adapt with the
environment. Waiting for cells to remodel so much of its own tissue (5 and 7 days) would
also be problematic because cellular heterogeneity may be more widely observed. These
considerations are imperative when analyzing cells in future experiments. Subsequential
studies were conducted to observe if cells can remodel their environment quicker if
exposed to mechanical force as they will experience in vivo.
4.3.2 Numerical Prediction of GelMe Hydrogel to Compressive Device
To further understand the change of the homogeneity of the environment, it is
crucial to use a computational numerical simulation to understand the gradient of the stress.
The testing was to be conducted at 75% gel height and 50% gel height due to compression
(25% & 50%). These were chosen to represent the elastic and plastic phases of the gel
respectively. When representing the 25% of hydrogel’s height, it was found that the stress
was about 0.5 kPa in the center and 1 kPa in the edge. As for 50% of hydrogel’s length, the
stress applied at the center was 1 kPa and 1.5 kPa at the edge (Fig. 28). Therefore, when
the loading was applied on the gel causing 25% of strain, most of the impact occurred at
the edge leaving the cell cellular volume, sphericity, and nuclear YAP localization about
the same when loading was applied. On the other hand, when loading caused 50% of strain,
even though the edge was more impacted, the cellular behavior was equally impacted
which may be a result of an optimum force applied. Table 1 shows the forces and stress on
the hydrogel under compression.
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Figure 28
Hydrogel Compression Simulation. FEBio was used to simulate local stress differences
within the hydrogel with compression of 25% and 50%.

4.3.3 Compressive Device Alters Cellular Morphology
The construct was made to provide insight on how cells can remodel their
environments based on stiffness gradients and model cell behavior in contractile and less
contractile environments along with the forces that affect their behavior. The simulation
described above predicted the forces on the gel under compression, and due to the
compression, gels would have a stiffness gradient. Stiffer regions of the gel were quantified
to be the edge of the gel or the outer 25% of the diameter of the gel (outer 2 mm) and were
hypothesized to have a larger more spread population of cells (Figure 29). Meanwhile, the
inner 50% of the diameter of the gel (inner 4 mm) was hypothesized to be softer which
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allowed for less mechanotransduction of cells and a more spherical shape signaling less
remodeling hydrogel remodeling.
Three different types of hydrogels were tested to investigate the cellular response
to mechanical stimulation. All hydrogels contained cells and were exposed to the forces
for 3 days due to the lack of extreme remodeling of the hydrogel network and expansion
of the cell. It was hypothesized that when exposing cells to an environment with
mechanical forces they would degrade their surroundings in a faster time dependent
manner than what was shown in the timepoint experiment. The first group was a control
with no force applied or 0% compression. The second group was exposed to a compression
bolt which deformed the hydrogel to 25% of its original height or 1.65 mm and the third
50% compression was 1.05 mm in height as shown in Fig 29.

Figure 29
Design of Compression Experiment. Experimental design of cell encapsulated hydrogel
compression.

Hydrogel Stress

high

Cell Morphology

low
GelMe
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Results demonstrate the cells sensed the mechanical loading from the compressive
device as shown in Fig 30. It was found that, at 25% strain, the cellular volume increased
by 1.5-fold to 15,138.68 μm3 when comparing cells at the edge of the hydrogel but no
major changes at the center when compared to the control (7198.65 μm3 vs. 8160.57 μm3).
The sphericity decreased slightly at the edge (0.57) and there were no significant changes
in the center (0.619 vs. 0.655). The same trend applied to nuclear YAP as it was greater
towards the outer edge of the gel when compared to the center 1.77 vs. 1.37. Therefore,
when 25% of the original height of the hydrogel was compressed, the cells responded to
the mechanical stimulation and were remodeling the hydrogel quicker than the control.
This observation is important when considering how to increase mechanical activity of
cells and could potentially lead to further studies which observe differentiation.
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Figure 30
Compression Device Data. Figure 30 a, b, c shows cellular volume, sphericity, and nuclear
YAP of 0%, 25% and 50% compression via bar graph and histogram. Cells > 50
*p<0.0001.

At 50% strain, a major force difference is displayed throughout the entire gel and
is larger than the other groups. Fig 30 also showed that the distribution of the cells’
morphology (volume, sphericity, and YAP) in the edge and center when the hydrogel was
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exposed to 25% and 50% of the strain. When no forces were applied, the cells were
encapsulated in a more homogeneous environment compared to the one exposed to the
compressive device (cellular volume between 5000 μm3 and 20000 μm3, sphericity
between 0.5 and 1, and Nuclear Yap between 0.7 and 2).
When there was less stress, the results of the compression and control were
comparable across all three markers. However, the more the hydrogel was exposed to
mechanical loading, the more stress on the hydrogel creating an environment that varies
with stress. Fig 31 shows the morphology of the cells throughout the different stress loads.
The cell spreading was almost uniform when the hydrogel was exposed to 50%
compression which signified that a constant stress was applied throughout the gel resulting
from maximum compression. As for 25%, it was found that the cell is more spread towards
the outer diameter of the hydrogel than the center and therefore can sense the gradient
stiffness and remodel the hydrogel quicker. These findings make it clear cells can respond
to the environment they are in and mechanical forces influence time dependent remodeling.

Figure 31
Compression Morphology. Cellular morphology when exposed to compression.
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After analyzing the cellular remodeling, it was crucial to investigate the mechanical
loading ability of the hydrogel. This was vital to the success of future studies since the PCL
scaffold would cause a high stress region of the hydrogel closest to the PCL edge and a
low stress region in the center of the pore of the composite. This phenomenon can be
attributed to hydrogel swelling as it swells in the pore of the PCL scaffold while submerges
in media. As such, using experimental and numerical simulation, 25 and 50% strain of the
hydrogel was used to understand the cellular response and demonstrate cells can sense
stiffness gradients. It was clear that the cells are resistant to a threshold of stress. When the
pressure of 2370 Pa was applied on GelMe and 1.0 kPa of stress was applied on the center,
the cellular morphology on the outer diameter was equivalent when there was no pressure
applied. However, when the strain was increased two folds, then the cells reacted
homogeneously with the loading. The results of the compression experiment can have
significant impact on the design of an environment that encourages cell heterogeneity.
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Table 1
Computational Model. This table respresents the parameters of stress and stress on the
hydrogel during compression via FEBio software.
PARAMETERS

DESCRIPTION

Pressure 25% strain

1230 Pa

Pressure 50% strain

2370 Pa

Condition at the bottom Fixed x,y and z
Condition at the top

Fixation

Diameter

8 mm

Height

1.6 mm

Density

1.02

Young’s Modulus

7 kPa

Poisson’s Ratio

0.499

4.4 Conclusions
When exploring cellular distribution to stress, it was found that, even when the
stress of 0.5 kPa was applied, the MSC environment was more homogenous than compared
to the higher stressed group. Therefore, other than remodeling, a higher loading from the
surrounding causes diverse conditions. The supplemental figure further proved the
hypothesis (Figure B1). When observing the results of 25% strain at the center versus no
stress applied, we could predict that a lower cellular volume and higher sphericity are
proportional to lower nuclear YAP localization. Results showed cells were not sensing
changes from mechanical loading and confirms the lower limit of detection these cells

58

sensed to 0.5 kPa in stress. On the other hand, the observable force and proportionality can
be confirmed at 50% strain as the cells display mechanotransduction and homogeneity.
When analyzing results of the compression experiment, it was clear that, at 25% edge, 50%
center, and 50% edge, the environment was under higher stress which caused an increase
in cell mechanical adaptation. Also, it was evident that at 0% and 25% center, the
environment did not have enough stress to quicken remodeling.
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Chapter 5
PCL Scaffold Mechanical Characterization and Fabrication
5.1 Introduction
Scaffold fabrication and biomaterials can be made through various processes as
reported in Chapter 3. PCL was chosen for this project due to its biocompatibility,
degradation properties, mechanical strength, and its ability to provide cells a 2D
environment based on its greater than 100 µm fiber diameter [13], [53]. The most ideal
process for this thesis was the Salt Leach Technique or Solvent Casting and Porogen
Leaching as this would potentially allow for cell harvesting in the pores of the scaffold.
Upon design of the scaffold, a few objectives were taken into consideration throughout the
entire fabrication process. The architecture has a key role in cell proliferation, transport,
differentiation, vascularization, tissue growth, and mechanics [53] Pore size, distribution,
interconnectivity, pore shape, porosity, and fiber diameter all have an impact on the cell in
terms of proliferation, differentiation, and phenotype. For a scaffold to provide necessary
environmental factors mimicking the OI, it should be highly porous and have full
interconnectivity, which will provide the maximum available surface are for cell
attachment and allowing transport throughout the scaffold [53].
However, prior to settling on this technique, a version of extruding and electrospinning
was brainstormed. In short, the electrospinning process consists of an electric field, an
acceleration of a charged jet of polymer solution towards a grounded collector which forms
a polymer solution. The solvent evaporates during the ejection and stretching of the jet
which allows for a fiber to be formed and collected on the plate. This method was not
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pursued after the lack of compressive strength of electro spun fibers. It is hypothesized
scaffolds for cartilage tissue engineering should employ a pore size of ~ 200 µm, whereas
scaffolds for bone tissue engineering should contain pores larger than 300 µm to enhance
vascularization [50]. This hypothesis was the rational for selecting NaCl sizes for the
various scaffold types however, it is important to know optimum pore size varies with
porosity and type of biomaterial used. Bone specific scaffolds have been created with pores
ranging between 20 – 1500 µm and while large pores have a positive result as in, they
encourage ECM formation, smaller pores also have benefits in that they enhance cell
proliferation and maintenance of phenotype and therefore, suggests a scaffold ranging in
pore size may encourage different cell lineages [53].
Before scaffold fabrication was chosen an extruding technique used with the help of
the mechanical engineering department was investigated. This technique consisted of
melting the polymer (PCL) with NaCl crystals and running it through an extruder.
However, this process was inefficient as the salt became embedded deeply in the dissolved
PCL and was unable to be leached out. Another caveat of this method was its lack of
structure. The extruded PCL was ~2 mm in diameter which left the project with an almost
futile solid scaffold. Therefore, both above techniques were abandoned and after discussion
with other members of BME and literature review, a salt leaching process was studied.
5.2 Methods
5.2.1 Scaffold Fabrication
The PCL scaffold was synthesized using the salt-leaching technique as described
previously [107], [121]–[124] as shown in Fig. 32. PCL scaffolds were created using the
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weight-to-weight technique. Scaffolds were created with PCL to DCM weight percentages
of 15, 20, 25, 30, 40 and 50%. 30 wt% was the final weight percent chosen for the
continuation of research and a sample calculation is as follows. 30% of the mass of PCL
was mixed with 70% of the mass of dichloromethane (DCM) (the mass was calculated
using the density and the volume). Varying wt% PCL scaffolds were created by changing
the amount of PCL dissolved in DCM.
NaCl between 200 µm and 500 µm was sieved using a borrowed salt sieve. PCL
concentrations were made with a varying ratio of from 2:1, 3:1, 4:1, 6:1, 8:1, 12:1, and
15:1 salt-to-PCL. 40 wt % was also fabricated at 3:1 and 4:1 NaCl to PCL. The mixture of
DCM and PCL was evenly distributed with NaCl, poured into a mold made from a Petri
dish, and let DCM evaporate for 24 hours in a fume hood. After DCM evaporation, a biopsy
punch (8 mm diameter) was used to create a dry PCL NaCl scaffold. The last step in
obtaining porosity was washing the PCL scaffold in DI water for 5 days changing the water
twice daily to leach out the NaCl. Figure 32 shows a representation of the process used to
create a porous scaffold.

Figure 32
Salt Leaching Technique. Fabrication process of PCL scaffold.
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5.2.2 SEM
The porosity of the PCL scaffold was measured using scanning electron microscopy
(SEM). After drying the scaffold and spin-coating it, it was exposed under the SEM
machine to visualize the porosity. The porosity was quantified by implementing the SEM
images into the FIJI software. The pore size was computed by averaging the diameter of
the pore diameter in the PCL scaffold. The porosity was determined to choose an optimal
PCL scaffold as it is clear to directly affect the mechanics. To further prove porosity was
present, the scaffolds were submerged in blue food coloring for porosity verification. The
scaffold showed food coloring was present through the entire structure, validating the
hypothesis it was porous (Fig 33).

Figure 33
Porous PCL. Image of the porous PCL scaffold cut in half. The blue dye perfused through
represents the permeability of the scaffold.
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5.2.3 Mechanics
PCL scaffold was dried at room temperature overnight then analyzed for Young’s
Modulus. The strain rate was set to 0.1%/min and the Young’s Modulus was calculated
between 10 and 20% strain for a maximum of 30% strain for all tested groups.
5.2.4 Nile Red Fabrication
Nile red was used to fluoresce the PCL. The NaCl scaffold became fluorescent with
the incorporation of Nile red to the DCM & PCL mixture. Nile Red was 99% pure and
distributed from Acros Organics. 0.1 mg Nile red was dissolved in 20 ml DCM. This was
then diluted using the serial dilution method with 1-part Nile red DCM and 10 parts DCM.
Scaffold fabrication was then followed as mentioned above with a 30 wt % NaCl. This
scaffold is shown in figure 34.

Figure 34
Nile Red PCL. Picture of Nile Red scaffold.

64

5.2.5 Perfusion
Due to the porosity and mechanical stiffness of the PCL scaffolds, MSCs were
perfused through the five-weight percent to observe whether this type of environment could
host living cells. To conduct this experiment, 15, 20, 25, 30 and 50 wt% PCL scaffolds of
2:1 NaCl to PCL were sterilized by submerging them in ethanol for 5 minutes followed by
washing 3x with sterile PBS. Scaffolds were then submerged in 10% FBS media and left
in the incubator for 24 hours to encourage cellular adhesion with a hydrophilic
environment.
Cell seeding included passaging as mentioned above followed by perfusion of
MSCs through a PCL scaffolds using media. The elementary seeding procedure consisted
of resuspending 200k cells in 1 ml of media followed by using a syringe and needle inserted
1 mm inside the scaffold to inject the and perfuse the media through the scaffold at constant
speed. This process was repeated 5 times for each scaffold. After 3 days of incubation the
cells were fixed and stained with phalloidin and Hoechst according to the procedures
mentioned in chapter 4. Later, the scaffolds were imaged to observe cellular adhesion to
the PCL.
5.2.6 Customized Perfusion Device
To remove all variables from the cellular seeding method, a customized perfusion
device was assembled. Using a syringe pump programmed at 1ml/min, an 8 mm diameter
plastic tube, and a syringe loaded with cell infused media, the customized perfusion device
was created. To seed each scaffold, the scaffold was fit tightly against the inner diameter
walls of the tubes and held in place via friction. The syringe was loaded with 1 ml of cell
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infused media and then the needle of the syringe was inserted into the scaffold of 1 mm in
depth. The syringe, tube, and scaffold were then placed horizontally as the syringe was
placed in the syringe pump. The syringe pump was turned on and media was perfused
through the scaffold at 1 ml/min (Fig. 35). Another syringe was attached to the opposite
end of the tube and collected the media after the first syringe’s load was empty. This
process was repeated for a total of 3x. After perfusion of media through the scaffold, the
scaffolds were placed in a 24 well plate dish, submerged with the remaining cellular media
and incubated for 3 days before staining and imaging.

Figure 35
Customized Perfusion Device. Depiction of customized perfusion device.

5.3 Results and Discussion
Five different scaffolds were created in the beginning process and the SEM images
are shown in the appendix section. The mechanical properties of the PCL scaffold created
by the salt leach method were adequate to mimic an osteochondral interface as the young’s
modulus of cartilage has been reported to range from 0.3 - 4 MPa [125]–[127].
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Figure 36
SEM Images of PCL Scaffold. A) represents the porosity of the low, medium, high. B)
represents the mechanics of the low, medium, and high porosity scaffold.

Low Porosity

High Porosity

500 µm

A 30 wt% of PCL scaffold was synthesized with a varying amount of salt (NaCl).
The more NaCl was added, the smaller is the Young’s Modulus and the larger porosity is.
Porosity was shown to have a direct effect on the mechanics of the scaffold. Pictured in the
SEM images are the 6:1, 8:1, 10:1, 12:1, & 15:1 NaCl to PCL scaffolds. Appendix C
characterizes the data representing early scaffolds. It is clear and apparent pores exist in all
images and there are larger pores as the ratio is increased. Low porosity was represented
by having porous sides far from each other and an 8:1 NaCl to PCL ratio and pore diameter
averaging 283 µm. Medium porosity was defined as 12:1 with pores averaging 319 µm.
For reference and ease of terms, 8:1 is represented by the term low porosity, 12:1 is medium
porosity, and 15:1 is high porosity. Lastly, a high porosity scaffold was represented by
larger pores that were on average 430 µm. The PCL scaffold with low porosity had
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Young’s Modulus about 500 kPa and decreased as average pore diameter increased (Figure
37).

Figure 37
Characterization of Scaffolds. A) Represents the porosity of the low, medium, and highly
porous scaffold. All scaffolds were in the range of 200 – 500 µm in pore size. B) Represents
the Young’s Modulus of the scaffolds. As the porosity increases, Young’s Modulus
decreases. N>5. Ns is no statistical difference, *p <0.05, **p<0.01, ***p<0.001,
****p<0.0001.

The medium scaffold had a modulus of 228 kPa meanwhile, the high porosity was
about 66 kPa. These results demonstrate a clear relationship with average pore diameter
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and mechanical stiffness of the scaffold. This small difference in average pore size had a
major impact on the stiffness. It is also interesting to note that the mechanics of the dry
PCL scaffold were greater for each group when compared to the composite of the
respective group. The variances in pore size may be attributed to the salt crystals
aggregating together and forming larger pores. These findings may be a result of the
hydrophilic properties of PCL and the affect and aqueous environment had on the PCL.
5.4 Conclusions
The mechanical properties of the PCL scaffold were proven to be important in this
work. It was found a higher amount of salt decreases the mechanical strength of the scaffold
because of the increase in porosity. There was a 200 μm increase of the porous diameter
from the highly porous scaffold to the low porous scaffold. Therefore, other than looking
into the amount of PCL, controlling the amount of NaCl can completely change the
properties of the scaffold. This could be explained as with greater porosity comes smaller
PCL components of the scaffold with less structural PCL volume.
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Chapter 6
Porous Scaffold and Soft Hydrogel Composite
6.1 Introduction
With the previous experimental results, and the knowledge of a potential stress
difference within the pore due to hydrogel swelling and stiffness difference, the hypothesis
cells can sense their environment was formed. Also, it could signify that the composite
allows for quicker remodeling than cells in GelMe alone which is resulting from the stress
gradient. At low porosity, the cells could be larger and more spread due to the force the
PCL exerts on the gel in the pore is greater as there is more surface area of PCL. It is
believed this would allow for a heterogenous population to exist in the composites with the
highly porous scaffold having a more heterogenous population than the low porosity
composite. This assumption was concluded when analyzing the pore size which the highly
porous composite may have a less force exerted on the cell in the center and less stressful
environment overall than the low porous scaffold. This conclusion would be important
when examining the biomedical application of the composite because the cellular
morphology can indirectly influence MSC differentiation [128].
6.2 Methods
6.2.1 GelMe Coupled with GFP
GelMe was coupled with green fluorescein peptide (GFP) and synthesized to
explore the potential of seeding an injectable hydrogel into PCL scaffold then form the
hydrogel using photopolymerization technique. To achieve that, GelMe macromer was
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coupled with Green Fluorescein Peptide using Michael-Type Addition technique [129],
[130].
First, triethanolamine (TEOA) buffer with pH 8 was formed by mixing 0.2 M of
TEOA with PBS for 30 minutes. Next, the pH of the solution was adjusted using traditional
techniques to achieve a pH of 8. Next, GFP was synthesized using solid-phase peptide
synthesis (SPPS). The sequence of the peptide was carboxyfluorescein-glycine-glycineglycine-cysteine. Glycine was used due to its flexibility and cysteine was used as it contains
a thiol group that will couple with GelMe during the Michael-type reaction. The peptide
was cleaved with 92.5% of trifluoroacetic acid (TFA) + 2.5% triisopropylsilane + 2.5%
2.2’-(Ethylenedioxy)diethanethiol + 2.5% pure water for 3 hours. Next, the peptide was
precipitated twice in cold diethyl ether by centrifuging at high speed for 5 minutes. Next,
the peptide was dried overnight, frozen to -80 °C and then lyophilized for 4 days. The
peptide was tested in H NMR to show its presence. The GFP was mixed with PBS to create
a 10 mM molarity.
The coupling occurred by mixing 5 wt% GelMe with 0.1 mM of GFP in 0.2 M
TEOA at a temperature of 40 °C for 1 hour. Next, the coupled macromer was dialyzed for
2 days by changing the water twice daily at a room temperature of 37 °C. Next, the
macromer was frozen in -80 °C and lyophilized for 5 days and then tested in H NMR to
display the presence of GFP in GelMe.
The GelMe coupled with GFP was mixed with unlabeled GelMe to investigate the
right concentration of GFP in GelMe hydrogel. This is done by mixing 5 wt% of labeled
and unlabeled GelMe in PBS and 0.05 wt% I2959. The hydrogel was injected into the
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PDMS mold biopsied with 8mm diameter and exposed to UV light with an intensity of 10
mW/cm2 for 10 minutes. The hydrogel was washed twice thoroughly in a room with lower
light exposure and then was analyzed in a confocal microscopy room. The images were
tested in FIJI using a plot profile to test the average intensity.
Once the concentration was optimized, the labeled and unlabeled GelMe hydrogel
was injected into the Nile red PCL scaffold to prove the presence of hydrogel in the
scaffold. The coupled and uncoupled GelMe injectable hydrogel was injected in the
different porous sides of the PCL scaffold using the customized perfusion device shown in
Figure 3A. The composite was exposed to UV light for 10 min for an intensity of 10
mW/cm2 then was washed thoroughly. The composite biomaterial and Nile red PCL
scaffold without hydrogel were tested in confocal microscopy to prove the presence of
hydrogel.
6.2.2 Stiffness
The composite scaffold was created by using two biomaterials, PCL and GelMe.
This was made by combining the GelMe hydrogel and PCL scaffold (optimal scaffold).
This was done by designing a customized perfusion device that included an 8mm diameter
plastic connected to a syringe attached to a syringe pump. Using tweezers and surface
friction, the scaffold was held perfectly in place in the tube. The syringe was filled with
GelMe solution and perfused through the tube injecting the GelMe hydrogel solution into
the PCL scaffold through the pores. The scaffold and remaining solution were injected into
a well plate and then the mixture was exposed to UV light for 10 min under an intensity of
10 mW/cm2. The biomaterial went through the same mechanical testing technique. The
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strain rate was set to 0.1%/min and the Young’s Modulus was calculated between 10 and
20% strain for a maximum of 30% strain.
For the PCL scaffold, MSCs were seeded into PCL using the customized perfusion
device shown in Figure 35. The procedure was similar except one million MSCs were
passaged and resuspended in 1 mL of the GelMe solution. The syringe was then loaded
with the GelMe MSC combination and placed on the syringe pump at a speed of 1 mL/min.
The composite was then exposed to UV light, washed in media 3 times, and then incubated
for 3 days.
6.2.3 Cell Staining
To analyze the cellular morphology, cells were stained for different biomarkers. First, cells
were fixed using 10% formalin for 15 min then 0.1% Triton X was added into the MSC
composite occupied well after 3 days of incubation to permeabilize the cell membrane.
Then, a composite was submerged in the blocking buffer solution (3% Bovine Serum
Albumin mixed in PBS) for 30 minutes. The primary anti-YAP was stained overnight in a
dark place due to YAP’s light. Several washes later, secondary anti-YAP tagged with
fluorescent was added and stayed for 2 hours in low light areas. After several washes later,
cells were stained with Phalloidin (1:100) and Propodium Iodide (1:300) to stain for
cytoskeleton and nucleus respectively. The cells were detected in the confocal microscope
and analyzed in FIJI software.
6.2.4 Fiji
Four metrics were analyzed using FIJI. Cell volume, cell shape index (CSI), aspect
ratio, and YAP nuclear localization. For each experiment, 100 cells were analyzed.
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Furthermore, binary masks of 3D image stacks of DAPI and Phalloidin were generated
using Otsu’s intensity-based threshold method. Next, the 3D object’s counter function was
used to determine the cell volume. The ratio of the largest and smallest side of the cell was
used to calculate the aspect ratio. After determining the volume and the surface area, CSI
will be calculated as follow:
1

2

𝜋 3 (6𝑉)3
𝐶𝑆𝐼 =
𝐴0
The CSI value will be between 0 and 1. Finally, the Nuclear YAP localization was
calculated:
𝑁𝑢𝑐𝑙𝑒𝑎𝑟 𝑌𝐴𝑃 𝑠𝑖𝑔𝑛𝑎𝑙
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑛𝑢𝑐𝑙𝑒𝑢𝑠
𝑁𝑢𝑐𝑙𝑒𝑎𝑟 𝑌𝐴𝑃 =
𝐶𝑦𝑡𝑜𝑠𝑜𝑙𝑖𝑐 𝑌𝐴𝑃 𝑠𝑖𝑔𝑛𝑎𝑙
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑐𝑦𝑡𝑜𝑠𝑜𝑙
The cytosolic YAP signal was determined by inverting and superimposing nuclei masks
with corresponding actin masks which lead masks encompassing the cytosol excluding the
nucleus. The Nuclear YAP signal followed the same method by concentration into masks
encompassing the nucleus and excluding the cytosol.
6.2.5 Statistical Analysis
All data are presented as 𝑚𝑒𝑎𝑛 ± 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑒𝑟𝑟𝑜𝑟. The graphs were created
using GraphPad software. The data were imported into a table then the graph was chosen
from the top menu depending on the type. The difference between values was calculated
using a one-way analysis of variance (ANOVA). Values of p<0.05 were considered to be
statistically significant. * With p-value was presented on top of the graph. A Histogram of
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cell spreading in the function of stiffness to understand whether the cell morphology was
high or low.
6.3 Results and Discussion
The peak of the carboxyfluorescein was shown in H NMR between 3 and 4 ppm
which was also shown in H NMR of the GelME coupled with GFP confirming the presence
of GFP. Fig. S3 represents the MALDI report of the GFP peptide. It was confirmed that
the actual molecular weight of the peptide was 650.369 Da compared to the expected one
which is 649.62 Da. The % of change of the molecular weight is 0.115% confirming the
accuracy of the peptide.
6.3.1 Cell Viability in PCL vs GelMe Gel Alone
GelMe hydrogel and PCL scaffold were synthesized separately, perfused, and
analyzed together. This was done as a goal to understand the biomaterial structure before
directly apply it to the TE field. First, the cell viability was tested in low, medium and high
scaffolds and gels alone. It was confirmed that high porosity decreases the stiffness of the
biomaterial and increased the cell viability. The cell viability was tested in PCL mixed with
gel and gel alone to test whether the composites were biocompatible. All the biomaterial
(scaffolds and gel alone) had very high viability shown in figure 38 (over 87%).
Additionally, it seems that the more porosity was increased, the higher cell viability is
confirming that the cells preferred a high porous material. The gels had much higher
viability than all the scaffolds.
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Figure 38
Cell Viability. Cell viability of the composite vs the GelMe alone. N>50 and ns is no
statistical difference.

6.3.2 GelMe Coupled with GFP and PCL Scaffold
Labeled GelMe hydrogel was formed to determine the minimum concentration
needed to get achieve a fluorescently green hydrogel. The GFP peptide was proven to have
a molecular weight of 650 g/mol as shown in MALDI. The peak representing GFP was
shown when analyzing GelMe + GFP in H NMR.
A concentration of 0.003 mM of GFP was used by combining 3% of GelMe labeled
GFP and unlabeled GFP. The next step was perfusing the labeled GelMe + GFP into PCL
with Nile Red as shown in Fig. 35. Supplemental Fig. shows the presence of labeled GelMe
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in the middle between the porous sides of red PCL. This confirmed that the mixture was
successfully made and injected into the PCL scaffold.

Figure 39
GelMe & GFP. A) Shows nile red pcl with GelMe perfused through the scaffold creating
a composite. B) Is a representation of nile red PCL alone. C) Displays the fluorescence of
GelMe+GFP compared against no GFP. D) Is a cartoon referencing how the composite
was imaged.

Before analyzing the cell morphology in the composite, it was highly important to
investigate whether the GelMe photopolymerized inside of PCL scaffold. This was done
by labeling PCL with Nile Red and GelMe with green fluorescence. Observing figure 39
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a, red PCL encircles the green hydrogel confirming the presence of GelMe. Therefore,
synthesizing composite could be achieved.
Perfusing cells encapsulated in GelMe injectable hydrogel into the PCL scaffold
was the next goal confirming whether increased remodeling and heterogeneity existed in
the composite. Therefore, a preliminary experiment was conducted to observe this, and the
results are shown in supplemental data (Figure D6, E1). Once encapsulation was
confirmed, the three varying scaffolds (low, med, high) were investigated and compared to
a GelMe alone control gel after 3 days. As previously hypothesized, the amount of porosity
had a major impact on the morphology. Cells presented in the low composite had a higher
cellular volume, lower sphericity, and YAP more localized to the nucleus compared to the
high porosity scaffold and the control. Even cells presented in high porosity composite had
higher mechanical activity than the control (Figure 40).
Therefore, the cells presented in the scaffold adapted to the loading applied by the
PCL and caused a variant environment compared to the control (Fig. 40 A). Cells tended
to be more circular in the middle and more spread towards the edge of the pore as shown
in Fig 40C. Supplemental figure confirmed the statement when analyzing this data via
histogram (Figure F1). When looking at gels, it was confirmed that lower cellular volume
and higher sphericity are proportional to lower nuclear YAP localization. Unfortunately,
not the same could be applied for the composite. This means that there was no correlation
between Nuclear YAP localization, cellular volume, and sphericity. This could possibly be
explained by the mechanical stimulus of the environment inside the pore. Analyzing
graphs, it is clear the data is statistically different from the composite groups against the
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control. The data shows that the composites were able to create an environment which
allows for quicker cell remodeling and more mechanical activity than in a hydrogel alone.
6.3.3 How Porosity Affects Mechanics
Depending on the porosity of the composite and mechanical stiffness MSC
behavior varied depending on the scaffold type (Fig. 40). The results display, lower
porosity contributes to an increase in the cellular volume (18000 μm3 vs. 10000 μm3), a
decrease in the sphericity (0.4 vs. 0.6) and higher Nuclear YAP expression (3.5 vs. 3). Even
though GelMe hydrogel is a soft hydrogel, its stiffness did not result in comparable
remodeling time, cellular volume, sphericity, and nuclear YAP.
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Figure 40
Composite Cell Data. A) Cellular Volume, sphericity, and Nuclear YAP expression. All
groups are compared against GelMe hydrogel alone. B) Morphololgy of cells in the
various composites presented via silhouettes. C) Image of the pore and cell morphology
inside as cells sense the stiff PCL. * P<0.05 signals significant when group is compared
against gel alone.

All three groups of composites demonstrated an increase in cellular behavior than
the hydrogel alone which may be contributed to the stress of the hydrogel is extremely
lower than all three groups. Fig. 40A shows the distribution of the cells when quantifying
cellular volume, sphericity, and nuclear YAP. The data shows a heterogeneous population
located in the pores of the composite and a potential stress gradient located in the pore
shown in Fig 40 A, B & C. It was found that cells in the hydrogel are more homogeneous
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compared to the one in PCL which could be explained by the mechanical stress applied by
the PCL scaffold onto the hydrogel. Not only can the stress difference within the pore be
created from the varying stiffness difference, but the hydrogel swelling properties. The
hydrogel is in a more restrictive environment when located in a smaller pore which could
be contributing to the stress difference.
6.4 Conclusions
The goal of this study was to observe the differences in cellular morphology
resulting from local environmental mechanics and to create a construct that may be used
for osteochondral tissue engineering. The environmental mechanics were hypothesized to
vary inside a pore of the composite due to the stress gradient proven to exist from during
the compression experiment. This was done to understand the effects of harvesting cells in
contractile and less contractile phases and to study the variances of cell morphology and
the forces that affect it in biomaterials while applying it to TE and recreate the
osteochondral interface as cell morphology has been shown to favor osteogenic or
chondrogenic differentiation.
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Chapter 7
Conclusions and Future Work
7.1 Conclusions
The result on cell morphology by the composite and the compressive device can be
widely applied for regenerative medicine. The compressive device confirmed when
exposing cells to mechanical load it can alter their morphology and time dependent
mechanical response. Furthermore, it showed that a heterogenous population can be created
due to mechanical force. This latter has prospect in regenerative medicine since it can be
used to create an interface at which soft and hard constructs meet. When tethering an
application for the composite a goal is recreation of the osteochondral interface. In turn,
this interface may induce differentiation of cells into osteoblasts and chondrocytes. Spread
mechanically active cells could represent the beginning of osteogenesis [131], [132]. On
the other hand, the rounded cells could represent the beginning of chondrogenesis [133] .
Therefore, this composite could one day be considered as a synthetic approach for
osteochondral interface engineering. The composite has the appropriate mechanics to
recreate the osteochondral interface and has proved to be a suitable environment for
harvesting cells.
Our work provides an exploration of a composite with gradient stress that provides
an environment created using biomaterials. In this work, PCL and GelMe hydrogel were
synthesized and mixed to understand the cell behavior when encapsulated in the pore. The
results showed that the hydrogel could be polymerized inside of the scaffold using light
and that a gradient of stress was created that cells respond to. Moreover, when cells were
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encapsulated in the hydrogel and far from any PCL backbone, they had a rounded, small
morphology without sensing mechanical stimulation from the environment. Moreover,
when the cells were located close to the edge of the pore, the cells had large and spread
morphology and had an increase in mechanosensing. These results have a great potential
in TE since they can be implemented for synthesizing any interfaces mimicking the natural
one including OI.
7.2 Future Work
Currently, lineage has not been studied. Mechanics of the composite and
morphology of cells have. However, future experiments could include further mechanical
tuning, observing cell lineage, and in vivo implantation.
7.2.1 Tunable Mechanics
Porosity and mechanics to exactly match the OI may be achieved. The composite
is highly tunable, and the mechanics and porosity can be achieved to allow bone
vascularization pore sizes greater than 300 µm and cartilage formation with pores smaller
than 200 µm. This can be done by coupling a low porous scaffold with a high porous
scaffold to allow bone vascularization while inducing cartilage formation by mechanics
alone. Also, the weight % can be increased to make the construct stiff and again, these
constructs may be layered on top of each other to create a gradient of porosity matching
the specific microenvironments. Lastly, the hydrogel stiffness may be manipulated by
increasing the wt % of the macromer. The increase will result in cells not as mechanically
active as they will be in a more restrictive hydrogel and will not remodel surrounding gel
as quickly.
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7.2.2 Chondrocytes and Osteoblasts
These studies may be done in the future using chondrocytes and osteoblasts instead
of MSCs. Perhaps harvesting chondrocytes from hyaline cartilage from the patient like
MACI and harvesting osteoblasts from the patient can yield better results. These results
may provide the backbone for expanding application of the composite to all types of joints
where bone meets cartilage. Allowing encapsulation of hyaline chondrocytes in our 3D
hard/stiff environment may yield greater success in reproducing the native cartilage and is
something that would be explored.
7.2.3 Thiol Norbornene Click Chemistry
Click chemistry is a practice used in engineering hydrogels. This process includes
modifying a backbone like hyaluronic acid (HA) with tiny elements for specific functions.
Essentially, an example of click chemistry is HA functionalized with norbornene groups.
The bonding uses a di-thiol crosslinker and forms a hydrogel and extra norbornenes can
undergo additional reactions. Norbonene has a few advantages in that it can bind to thiol
groups covalently during photopolymerization, it has an orthogonal system which allows
for more peptide binding with the thiol groups, and norbornene is biocompatible. The
peptide thiol binding is important for addition of biochemical signals to guide
differentiation [133], [134].
When using NorHA, the crosslinker would be dithiothreitol (DTT) allowing for cell
degradation. NorHA can be more protease degradable when using DTT than GelMe. Click
chemistry using NorHA allows for the incorporation of the biological signals to the
backbone of NorHA guiding differentiation of cells. For bone, BMP2 can be coupled with
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NorHA and Runx2 may be evaluated. NorHA can be coupled with HAV peptide and VEGF
encouraging cartilage formation along with evaluation of chondrogenic factors (Fig. 41).

Figure 41
Click Chemistry. A) NorHA is hyaluronic acid modified with norbornene and is a cartoon
representation of norbornene added to hyaluronan backbone and binding to each
norbornene. B) Biochemical signals coupled to the hydrogel backbone. [133]

7.2.4 In Vivo
In vivo implantation of the scaffold may be achieved by debriding the damaged
cartilage all the way to underlying bone but not denuding the bone. Next, the surgeon must
stabilize implant loaded with chondrocytes and osteoblasts onto the bone and affix it to the
bone. Another cartilage layer may be added on top of the composite using a collagen
scaffold seeded with hyaline chondrocytes similar to MACI. This added step will ensure
cartilage formation and the composite loaded with biological signals enhancing
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differentiation towards two lineages in combination with another layer of a MACI like
scaffold on top of the composite will ensure success of the composite in regeneration of
the osteochondral interface.
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Appendix A
HNMR & MALDI
Figure A1
HNMR of Hydrogel. A) GelMe HNMR. B) GFP HNMR C) GelMe + GFP HNMR
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Figure A2
Maldi of GelMe + GFP.
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Appendix B
Compression Experiment
Figure B1
Compression Experiments Supplemental Data. A) Shows cell volume sphericity and
nuclear YAP of all groups with individual points plotted. B) Shows YAP vs cellular volume
and C) displays YAP vs sphericity.
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Appendix C
Scaffold Characterization
Figure C1
Different Weight % of PCL Scaffolds Porosity.
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Figure C2
Porosity of PCL Scaffolds

Figure C3
Different Weight % PCL Scaffolds Mechanical Properties.
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Table C1
Mechanics of Early PCL Scaffolds.

Standard

Ultimate Compressive force

Elastic modulus kPa Deviation

MPa

15%
20%
25%
30%
50%

15%
20%
25%
30%
50%

798
3638
2463
5571
8215

0.234887438
0.965907863
0.594910148
0.448341055
0.379214296

Figure C4
Direct Comparison of Porosity and Mechanics.
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Standard
Deviation
6.118512843
9.951083239
9.696644221
9.889679273
9.820188246

1.955374499
0.000647102
0.178023484
0.085403443
0.010958538

Figure C5
Fluorescent Images with Cells in Early Scaffolds.

The elastic modulus produced from the scaffolds at a 2:1 NaCl to PCL ratio ranged
from 700 kPa to 8215 kPa. The large moduli can be attributed to a lack of porosity and salt
content. SEM imaging shows the lack of porosity throughout these scaffolds and results
demonstrated, mechanical properties increased as PCL wt % increased meanwhile,
porosity remained constant. The values of pore size for 15, 20, 25, 30, 50 wt% for 2:1 NaCl
to PCL ratio include 174 mm, 137 mm, 170mm, 207 mm, and 195 mm in diameter on
average. The small pore diameter can be attributed to the lack of NaCl crystals in the
scaffold as there was only a 2:1 ratio. However, the constant pore size and porosity in
conjunction with the increasing wt% of PCL are the main determinants of the increasing
mechanical properties. This finding can be explained from the fact as you increase PCL
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wt% and keep porosity constant by the amount of salt that is added, mechanics will
increase.
However, after analyzing cellular perfusion through the sterilized scaffolds, it was
concluded more porosity must be incorporated at the cost of mechanical properties. As it
is seen in the figure, after seeding scaffolds with 200k cells and staining their cytoskeleton
with PI in direct accordance with the procedure in chapter 4, there was a lack of cellular
population in the scaffold environments. The lack of cells could be from a multitude of
factors including the elementary seeding method, the lack of cellular concentration, and/or
the pore size. After careful evaluation of the factors affecting cellular adhesion in the
scaffold, it was concluded a perfusion method needed to be developed to provide
consistency in cellular seeding, porosity must increase, and cell concentration will be 500k
cells per ml moving forward to the next experiment. The mechanical properties were
compromised to increase the porosity in hopes cellular harvesting would be greater in the
scaffold. These mechanics resemble the tissues in the OI in terms of mechanics but to
increase porosity and encourage cellular proliferation in the scaffold, a more tortuous
structure is needed and therefore a compromise to mechanics will be introduced later.
As the mechanical properties of the 30 wt% construct was acceptable for cartilage
and perhaps the OI, this wt% was used for all future studies. To further study the effects of
porosity and cellular adhesion to the scaffold pores, another study was developed. This
experiment included increasing the NaCl:PCL wt% to 3:1 and 4:1. These scaffolds were
developed with the idea in mind to explore the effects on porosity for cell adhesion while
maintaining mechanical integrity. 40 wt% was also created to compare mechanical
properties. 3:1, 4:1 NaCl:PCL for 30 and 40% had an elastic modulus 4111, 4637, 5452,
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and 3652 kPa respectively. As these scaffolds were seeded with cells, the cell density was
500k/ml in media and they were seeded with the customized perfusion device shown in the
schematic at 1 ml/min and they left to incubate in the incubator for three days. The scaffolds
were fixed and stained with PI and Phalloidin and imaged. The images display an increase
in cell population in the scaffold due to porosity and perfusion method. Cells show
adaptiveness to the PCL by exhibiting spreading and large morphology. This is believed to
result from a rigid 2D environment. The high elastic modulus and large fiber diameter >
100 µm results in the cells adopting a morphology favoring osteogenesis.

Table C2
Mechanics with Increased Porosity.
PCL

Elastic Modulus (kPa)

3 x30
3x40
4x30
4x40

4111.6
4637.84
3813.2
3851.875
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Appendix D
Cell Tracker Experiments
Introduction
Cell tracking experiments were used to provide details on two different cell
populations harvested in the composite. Cell tracker red and green was used to stain cells
and the results are observed. The lower limits of detection for cell tracker green and red
were recorded to ensure the minimum interference with cellular behavior and activity. To
stain cells green and red and to find the lower limits of detection the subsequent protocols
were followed. Once it was shown that cells can indeed be harvested inside the PCL
scaffold and showed spread morphology it was hypothesized that if methacrylate hydrogel
was injected into the scaffold after harvesting cells with media only, there could exists a
co population of cells and based on morphology favor osteogenesis or chondrogenesis. To
track cell lineage and the different populations, it was essential to stain each cell type prior
to seeding and encapsulating the cells. To accomplish this task, the lower limits of detection
for cell tracker red and green must be found to ensure the least amount of cellular
interruption.
Methods
Staining for Cell Tracker Green
To create cell tracker green at 10 mM concentration the below protocol was
followed. First cell tracker green was ordered from VWR and 10.78 µl of DMSO was
added to cell tracker green. Next cells were thawed followed by passaging them in
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accordance with the above procedure. Cells were counted and separated to include 500k
cells in a 50 ml conical tube. Next, 5 ml of media with 10% FBS solution was added and
centrifuged for 5 minutes at 500 x g. The next step required aspirating the media and
resuspending the pellet in 3 ul cell tracker green solution and 5 ml serum free media. The
cells needed to be incubated for 30 minutes and perturbed every 10 minutes. It was
necessary to centrifuge the cells and wash 3x with 5 ml of media with 2% FBS by repeating
centrifuging, aspirating, and resuspending the cell pellet. Lastly, the cell’s nucleus was
stained by resuspending the stained cells in 0.5 ul Hoechst and 5 ml 10% FBS media and
washed 3x with the same procedure as mentioned above. To plate the cells for 10k cells
per plate, the 500k stained cells were resuspended in 0.5 ml of media and using a pipette
10 µl of cell solution was seeded on each glass coverslip and incubated. The results of the
stained cells are shown below.

Figure D1
Cell Tracker Green and Hoechst-Stained Cells.
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Lower Limit of Detection Cell Tracker Green and Red
To find the lower limit of detection for cell tracker green the procedure for thawing
and passaging the cells was identical to the procedure mentioned above. 10.78 µl of DMSO
was added to cell tracker green. Next cells were thawed followed by passaging them in
accordance with the above procedure. Cells were counted and separated to include 2
million cells in a 50 ml conical tube. Next, 5 ml of media with 10% FBS solution was
added and centrifuged for 5 minutes at 500 x g. The next step required serial dilutions.
These dilutions consisted of achieving four ratios of cell tracker to media which were
labeled A, B, C, D with ratios of 1:2000, 1:4000, 1:8000, 1:16000 respectively. The A
solution (1:2000) consisted of 10 ml media with 2% FBS and 5 ul cell tracker green. To
make solution B, 5 ml of solution A was diluted with 5 ml 2% FBS media for a ratio of
1:4000. For solution C, 5 ml solution B was diluted with 5 ml 2% FBS media to achieve
the ratio of 1:8000. Finally, the lowest limit tested, the concentration of 1:16000 was made
from 5 ml of solution C mixed with 5 ml 2% FBS media. To test the fluorescence of each
solution, 500k cells were added in 5 ml of each serial dilution. They were incubated for 30
minutes followed by centrifugation with the same properties as above and 3 washes with 5
ml of 10% FBS media. Then, cell pellets of solutions A, B, C, and D were resuspended in
1 ml of 10% FBS media and plated onto glass coverslips within a 24 well plate and
incubated for 1 day. The cells were imaged 24 hours later and qualitatively observed in
their 2D environment.
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Figure D2
Cell Tracker Green at Different Concentrations.

To create and find the lower limit of detection for cell tracker red at 10 mM
concentration the below protocol was followed. First cell tracker red was ordered from
VWR and 7.29 µl of DMSO was added to cell tracker red. Next cells were thawed followed
by passaging them in accordance with the above procedure. Cells were counted and
separated to include 500k cells in a 50 ml conical tube. Next, 5 ml of media with 10% FBS
solution was added and centrifuged for 5 minutes at 500 x g. The next step required serial
dilutions. These dilutions consisted of achieving four ratios of cell tracker to media which
were labeled A, B, C with ratios of 1:5000, 1:10000, 1:20000 respectively. The A solution
(1:5000) consisted of 10 ml media with 2% FBS and 2 ul cell tracker green. To make
solution B, 5 ml of solution A was diluted with 5 ml 2% FBS media for a ratio of 1:10000.
For solution C, 5 ml solution B was diluted with 5 ml 2% FBS media to achieve the ratio
of 1:20000. To test the fluorescence of each solution, 500k cells were added in 5 ml of each
serial dilution. They were incubated for 30 minutes followed by centrifugation with the
same properties as above and 3 washes with 5 ml of 10% FBS media. Then, cell pellets of
solutions A, B, and C were resuspended in 167 µl of 10% FBS media and 10 µl was plated
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onto glass coverslips within a 24 well plate and incubated for 1 day. This achieved 10k
cells on each coverslip with a 1:1 cell/ml seeding density. The cells were imaged 24 hours
later and qualitatively observed in their 2D environment.

Figure D3
Cell Tracker Red at Different Concentrations.

Hoechst Lower Limit of Detection with Cell Tracker Red
A further experiment was conducted to observe the lower limit of detection for
Hoechst in these cell tracker studies. These studies were completed using cell tracker red
at a dilution factor of 1:5000. The above protocol was followed. Serial dilutions were used
to dilute Hoechst to the desired amounts of A, B, and C. The procedure for Hoechst
solutions is as follows: Solution A, add 1.5 ul of Hoechst to 10 ml 10% FBS media
(1:6,666). Solution B, take 5 ml of solution A and dilute it with 5 ml 10% FBS Media for
1:13,333. For solution C, take 5 ml solution B and dilute with 5 ml 10% FBS Media for
1:26,666. These solutions were plated and imaged after 24 hours of incubation.
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Figure D4
Cell Tracker Red and Hoechst at Different Concentrations.

Co-population of Cell Tracker Green and Red
Once it was confirmed that cells were able to be seeded and stained with cell tracker
green and red it was necessary to test whether green stained cells and red stained cells can
exist as a co-population on one glass plate. Therefore, an experiment was conducted to
study the ability to stain two populations of cells and observe their color heterogeneity. To
stain for cell tracker green, the solution for staining of cell tracker B solution was followed
and to stain the cells red, the procedure for cell tracker red solution A was followed. The
resuspended solution of pellets for cell tracker green and red were then mixed and plated
on a well plate. These plates were imaged 24 hours later after incubation.
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Figure D5
Co-population of Cell Tracker Green and Red.

Cell Tracker Perfusion Through PCL
After successfully showing green and red cells can exist simultaneously, it was
hypothesized that there could be an observation of two cell populations seeded inside the
PCL scaffold based on morphology. Using previous results showing round and spread cells
in the scaffold, the objective was to encapsulate red cells in GelMe hydrogel and perfuse
that through the scaffold after seeding green MSCs through the scaffold. The goal was to
show that green cells would be spread (2D), and red cells would be round as they live in a
3D environment.
First, cell tracker green was used to stain a population of cells 500k cells (1 million
cells per ml). Next the group of green cells were perfused through the low porosity PCL
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scaffold using the perfusion method described below with 500k cells in media. After 1 day,
another group of cells were stained with cell tracker red following the protocol above. 500k
cells with cell tracker red were resuspended in 0.5 ml of 5 wt% GelMe solution and then
perfused through the scaffold with cell tracker green cells inside. The scaffold was exposed
under U V light with an intensity of 10 mW/cm2 for 10 minutes. The composite was washed
3x with media and incubated for 3 days.
Results and Discussion
Cell tracker green could be observed to stain cells at the lowest concentration
recorded which was 1:16000. Cell tracker red could be used at a concentration of 1:5000
before the fluorescents started to become dim and skew qualification. Hoechst staining
should not go lower than 1:6,666 for these experiments as the nuclei were not as bright
with lower concentrations. Next, it was displayed via confocal microscope green and red
stained MSCs could co-populate in one environment without color leaching. This finding
was the foundation needed to proceed the following experiment of dual seeding cell
populations in the scaffold. MSCs that were stained with cell tracker green and perfused
with media were not visible after the group of red MSCs were perfused with GelMe and
encapsulated.
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Figure D6
Cells Encapsulated in GelMe Labeled with Cell Tracker Red Perfused Through the
Scaffold. No visible cells perfused through with cell tracker green.
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Appendix E
Preliminary Composite Data
Figure E1
Preliminary Composite Data to Show the Composite Can Harvest Cells. C) Shows early
co-population evidence of cells.
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Table E1
Table of Frequency of Round vs Spread Cells in Low and Medium Composite.

Spread
Cells
220
Low
Medium 141
69
gel

Round
cells
128
187
183

Total
348
328
252

Frequency
spread
0.632183908
0.429878049
0.273809524
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Frequency
round
0.367816092
0.570121951
0.726190476

Appendix F
Supplemental Composite Data
Figure F1
Composite Histogram Data. A) is histograms of cell volume, sphericity, and nuclear YAP.
B) Is YAP localization vs volume and sphericity.

Figure F2
Cell Images in Low, Med, High Composite.
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Figure F3
Cell Images in Nile Red. Displays the medium composite exhibiting cellular sensing as
cells are close to pore edges.
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